Inventor · disambiguated record
Meiyu Geng
Also filed as: GENG MEIYU
35 granted patents·19 pending applications·54 citations·filing 2005–2023
94Inventor score
Files withSHANGHAI INST MATERIA MEDICA CAS17GREEN VALLEY SHANGHAI PHARMACEUTICALS CO LTD9SHANGHAI GREEN VALLEY PHARMACEUTICAL CO LTD6SHANGHAI HAIHE PHARMACEUTICAL CO LTD5HAIHE BIOPHARMA CO LTD3
Top patents by PatentIndex Score
54 records- 0189US8835403B2Algin oligosaccharides and the derivatives thereof as well as the manufacture and the use of the sameGENG MEIYU·Filed 2005·Granted Sep 16, 2014·31 cites·10 claims
- 0288US9493496B2Algin oligosaccharides and the derivatives thereof as well as the manufacture and the use of the sameOCEAN UNIV CHINA·Filed 2014·Granted Nov 15, 2016·12 cites·4 claims
- 0381US10829491B2Pyrimido[5,4-B]indolizine or pyrimido[5,4-B]pyrrolizine compound, preparation method and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2017·Granted Nov 10, 2020·3 cites·8 claims
- 0479US11155569B2Method of degrading polysaccharide using ozoneGREEN VALLEY SHANGHAI PHARMACEUTICALS CO LTD·Filed 2017·Granted Oct 26, 2021·1 cites·18 claims
- 0574US12269838B2Composition of mannuronic diacidGREEN VALLEY SHANGHAI PHARMACEUTICALS CO LTD·Filed 2022·Granted Apr 8, 2025·0 cites·17 claims
- 0673US11406652B2Use of mannuronic diacid composition in treatment of diabetesGREEN VALLEY SHANGHAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Aug 9, 2022·1 cites·17 claims
- 0773US10213456B2Alginate oligosaccharides and the derivatives thereof as well as the manufacture and the use of the sameOCEAN UNIV CHINA·Filed 2016·Granted Feb 26, 2019·1 cites·3 claims
- 0873US9206166B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2013·Granted Dec 8, 2015·2 cites·20 claims
- 0970US11384111B2Composition of mannuronic diacidGREEN VALLEY SHANGHAI PHARMACEUTICALS CO LTD·Filed 2017·Granted Jul 12, 2022·1 cites·18 claims
- 1068US10683278B2Substituted quinolone derivatives, or pharmaceutically acceptable salts or stereoisomers thereof, and pharmaceutical compositions and use thereofUNIV JINAN·Filed 2016·Granted Jun 16, 2020·1 cites·11 claims
- 1164US10059694B22-aminopyrimidine compound and pharmaceutical composition and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2015·Granted Aug 28, 2018·1 cites·15 claims
- 1259US2019255092A1Alginate oligosaccharides and the derivatives thereof as well as the manufacture and the use of the sameOCEAN UNIV CHINA·Filed 2019·Application pending·0 cites
- 1356US2025171415A1Salt of substituted amino six-membered nitric heterocyclic compound, crystal form thereof, method for preparing same, and use thereofSHANGHAI RUNSHI MEDICAL TECH CO LTD·Filed 2023·Application pending·0 cites
- 1454US12384795B2Pyrimido[5,4-b]pyrrolizin compound, optical isomer thereof, preparation method therefor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2020·Granted Aug 12, 2025·0 cites·14 claims
- 1554US2023382871A1Csf1r kinase inhibitor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2021·Application pending·0 cites
- 1653US11406653B2Use of mannuronic diacid composition in treatment of painGREEN VALLEY SHANGHAI PHARMACEUTICALS CO LTD·Filed 2019·Granted Aug 9, 2022·0 cites·17 claims
- 1752US11406654B2Use of mannuronic diacid composition in treatment of Parkinson's diseaseGREEN VALLEY SHANGHAI PHARMACEUTICALS CO LTD·Filed 2019·Granted Aug 9, 2022·0 cites·17 claims
- 1852US2024150300A1S-configuration-containing amino benzamide pyridazinone compound, preparation method therefor, and pharmaceutical composition and application thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2022·Application pending·0 cites
- 1951US2025032464A1Solid dispersion, preparation method therefor, and solid formulation containing sameHAIHE BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 2048US12479850B2Compound having Axl and c-Met kinase inhibitory activity, preparation thereof and application thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2020·Granted Nov 25, 2025·0 cites·7 claims
- 2148US10927137B2Method for preparing oligomeric mannuronic diacidSHANGHAI GREEN VALLEY PHARMACEUTICAL CO LTD·Filed 2016·Granted Feb 23, 2021·0 cites·17 claims
- 2248US2022280541A1Method for identifying carbohydrate drug-sensitive patient in patients having alzheimer's diseaseSHANGHAI GREEN VALLEY PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 2348US2022273598A1Method for treating alzheimer's disease by inhibiting uptake of amino acids by t cellsSHANGHAI GREEN VALLEY PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 2448US2023032101A1Five-membered heterocyclic oxocarboxylic acid compound and medical use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2020·Application pending·0 cites
- 2548US2022362271A1Use of mannuronic acid oligosaccharides or composition comprising same in treatment of th1-dominance related diseasesSHANGHAI GREEN VALLEY PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 2648US2022280589A1Method for treating alzheimer's disease by regulating amino acid levelSHANGHAI GREEN VALLEY PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 2747US2022280578A1Method for treating alzheimer's disease by regulating intestinal microorganismsSHANGHAI GREEN VALLEY PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 2846US12312324B2Fluorine-containing substituted benzothiophene compound, and pharmaceutical composition and application thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2019·Granted May 27, 2025·0 cites·10 claims
- 2946US11465984B2Compound having ERK kinase inhibitory activity and use thereofSHANGHAI HAIHE PHARMACEUTICAL CO LTD·Filed 2018·Granted Oct 11, 2022·0 cites·25 claims
- 3046US2022387477A1Pharmaceutical compositions containing alginate oligosaccharaide diacidGREEN VALLEY SHANGHAI PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 3145US12497394B2Fused-cyclic pyrazolone formamide compound and preparation method therefor, pharmaceutical composition and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2019·Granted Dec 16, 2025·0 cites·12 claims
- 3245US11406659B2Use of mannuronic diacid composition in treatment of inflammationGREEN VALLEY SHANGHAI PHARMACEUTICALS CO LTD·Filed 2019·Granted Aug 9, 2022·0 cites·18 claims
- 3344US12492212B2Substituted pyrazolecarboxamides as sting activatorsSHANGHAI INST MATERIA MEDICA CAS·Filed 2020·Granted Dec 9, 2025·0 cites·16 claims
- 3444US11406651B2Use of mannuronic diacid composition in treatment of vascular dementiaGREEN VALLEY SHANGHAI PHARMACEUTICALS CO LTD·Filed 2019·Granted Aug 9, 2022·0 cites·18 claims
- 3543US10766889B2Aryl-2,2′-tandem bisthiazole compound and preparation method and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2017·Granted Sep 8, 2020·0 cites·19 claims
- 3643US9988381B2Five-member-heterocycle fused pyridine compounds, method of producing the same, and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2014·Granted Jun 5, 2018·0 cites·21 claims
- 3742US9567342B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2015·Granted Feb 14, 2017·0 cites·20 claims
- 3841US11834432B2Substituted amino six-membered nitric heterocyclic ring compound and preparation and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2017·Granted Dec 5, 2023·0 cites·16 claims
- 3941US11655239B2Fused ring pyrimidine amino compound and preparation method, pharmaceutical composition, and use thereofSHANGHAI INSTITUTE OF MAT MEDICA CHINESE ACADEMY OF SCIENCES·Filed 2020·Granted May 23, 2023·0 cites·16 claims
- 4041US11464794B2Composition of alginic oligosaccharic diacidsGREEN VALLEY SHANGHAI PHARMACEUTICALS CO LTD·Filed 2019·Granted Oct 11, 2022·0 cites·17 claims
- 4141US2021261539A1Compound having bet inhibitory activity and preparation method and use thereforSHANGHAI HAIHE PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 4239US10988456B2O-aminoheteroaryl alkynyl-containing compound, preparation method therefor, and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2018·Granted Apr 27, 2021·0 cites·17 claims
- 4338US2014296216A1Pyrimido[4,5-d]pyrimidinyl compounds, pharmaceutical compositions and uses thereofDING KE·Filed 2011·Application pending·0 cites
- 4436US10710996B2Pyrido-azaheterecydic compound and preparation method and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2016·Granted Jul 14, 2020·0 cites·7 claims
- 4536US2013324542A1[1,2,4]triazolo[4,3-b][1,2,4]triazine compounds, preparation method and use thereofDUAN WENHU·Filed 2011·Application pending·0 cites
- 4635US11661421B2Indolizine compounds, preparation method and use thereofHAIHE BIOPHARMA CO LTD·Filed 2019·Granted May 30, 2023·0 cites·9 claims
- 4735US10682352B2Compound having mutant IDH inhibitory activity, preparation method and use thereofSHANGHAI HAIHE PHARMACEUTICAL CO LTD·Filed 2017·Granted Jun 16, 2020·0 cites·15 claims
- 4835US10562900B2Indazole compounds as FGFR kinase inhibitor, preparation and use thereofSHANGHAI HAIHE PHARMACEUTICAL CO LTD·Filed 2015·Granted Feb 18, 2020·0 cites·15 claims
- 4935US2019367520A1New compound having fgfr inhibitory activity and preparation and application thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2017·Application pending·0 cites
- 5034US2019135818A15-membered heterocycle fused with [3,4-d] pyridazinone, and manufacturing method, pharmaceutical composition, and application thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2017·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Meiyu Geng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →